Nidhi Panchmal and Dipalie Bajaj, co-founders of Arva Health
An India-based start-up has launched an at-home fertility test to help women track and monitor their hormones.
The test, developed by Arva Health, claims to measure up to 12 hormone levels that affect fertility at a more affordable cost than traditional fertility clinics.
The product, Arva says, is customised specifically for Indian women suffering from polycystic ovary syndrome (PCOS) and thyroid issues.
According to a report from the Office of National Statistics, more and more working women are choosing to have children later in life, often in their thirties, owing to the pressure of having to balance a family with their jobs, have a higher standard of living, and increasing cost of raising children. Over 95 per cent of women feel stressed and anxious about getting pregnant as they get older.
Bengaluru-based Arva says it aims to help women understand and take charge of their reproductive health, by giving them important information about their fertility and supporting them in making decisions.
“Women’s health in India has been overlooked for too long,” Nidhi Panchmal, co-founder of Arva Health, explained in a statement.
“At Arva, we believe that every woman deserves to know her body and we are committed to empowering women to make informed decisions about their reproductive future.
“Our Arva fertility test is a powerful starting point that helps women detect any fertility issues early and take control of their fertility journey, whether they want kids today or someday.”
Dipalie Bajaj, co-founder and CEO of Arva Health, said: “We aim to be a reproductive health concierge, helping users manage their health journey by recommending safe, vetted doctors, facilitating appointment bookings and connecting users with a community of individuals on a similar path.
“Many believe that women can conceive at the drop of a hat, but the truth is that most women are left in the dark about their fertility until they face challenges or consider an IVF clinic.
“Our solution is not just a diagnostic tool but a comprehensive journey into understanding oneself. Through our digital platform, women don’t just get results; they gain insights tailored to their unique history.”
Arva’s new at-home fertility test for women, Bajaj said, offers an “unprecedented opportunity” for women to understand their reproductive hormones in clear and straightforward language.
“The test includes often-overlooked tests like AMH and ovarian reserve and the reports offer personalised insights based on individual data, helping women understand how their lifestyle choices influence fertility health,” the co-founder added.
To receive the Femtech World newsletter,sign up here.
Researchers have created a therapeutic HPV vaccine delivered through the nose that could offer a non-invasive treatment for cervical cancer.
Screening for HPV and preventive vaccines lower risk, but there are no approved therapies for existing HPV infections or HPV-linked cancers.
Current treatments include surgery, radiotherapy and chemotherapy.
Researchers from Chiba University, Japan, led by associate professor Rika Nakahashi-Ouchida and Ms Hiromi Mori of Chiba University Hospital, have developed an intranasal therapeutic option.
Unlike injectable vaccines, nasal vaccines trigger immunity at the mucosal surface — the protective lining of the upper airway.
This mucosal response can also protect distant sites, including the reproductive tract.
Building on earlier work showing nasal immunisation can elicit strong genital-tract responses against herpes simplex virus type 2, the team used cationic nano-sized hydrogel particles (cCHP nanogels) to deliver HPV antigens to nasal tissues.
These positively charged spheres adhere to the negatively charged nasal surface and slowly release antigens, which prompt an immune response.
Nakahashi-Ouchida said: “We have developed an intranasal therapeutic vaccine as a non-surgical alternative to conventional treatments that can compromise women’s quality of life.
“This novel nasal vaccine activates the mucosal homing pathways of lymphocytes, allowing it to trigger an immune response in the cervical mucosa, a site from the nasal administration.”
The formulation targets the E7 oncoprotein from HPV16, which inactivates pRb, a key tumour suppressor.
To strengthen responses, the researchers added cyclic-di-AMP, an adjuvant that boosts T-cell-mediated immunity so T cells can attack infected or cancerous cells.
The resulting cCHP-E7 + c-di-AMP showed what the researchers describe as strong anti-tumour activity in mice and macaques. In mouse models, it significantly slowed tumour growth versus controls.
In macaques, a nasal spray device (usable in humans) delivered four doses.
Vaccinated animals developed high levels of E7-specific helper and killer T cells producing molecules linked to tumour control; controls did not.
Immune activity was detected in cervical tissue, and E7-specific killer T cells persisted for at least four months, suggesting lasting defence.
According to the World Health Organization, cervical cancer caused an estimated 660,000 new cases and 350,000 deaths in 2022.
If proven safe and effective in humans, intranasal therapy could offer a non-invasive, fertility-preserving alternative to surgery for some patients.
The cCHP nanogel platform may also support nasal vaccines against other pathogens and wider clinical uses.
Nakahashi-Ouchida said: “Immunotherapies such as intranasal therapeutic vaccines may help establish a new category of non-invasive treatment.
“These approaches could be extended to recurrence prevention and chronic disease management, offering patients safer and more accessible options.”
New research has uncovered biological differences that explain why women with long Covid experience more severe and persistent symptoms than men.
Long Covid is diagnosed when neurological, respiratory or gastrointestinal symptoms persist for three months or more after SARS-CoV-2 infection.
Women are about three times more likely than men to develop it, but the biology behind this gap has been unclear.
The research from the University of Alberta suggests potential treatment targets that could help the 3.5 million Canadians who reported long Covid as of June 2023, according to Statistics Canada.
Principal investigator Shokrollah Elahi is an immunology professor in the Mike Petryk School of Dentistry.
The researcher said: “We are focusing on a subset of patients with the most devastating symptoms that are very similar to chronic fatigue syndrome.
“They didn’t have these symptoms prior to Covid and most had only mild Covid-19 disease, so they were not hospitalised.”
Elahi’s team ran blood and genetic tests on 78 patients with long Covid one year after their acute diagnosis, plus 62 controls who did not develop long Covid after infection.
By analysing immune cells, blood biomarkers (measurable signals of disease) and RNA sequencing (a method to read gene activity), the researchers identified a distinct immune signature in female versus male patients.
They found evidence of “gut leakiness” in female patients — when the intestinal barrier becomes more permeable and allows substances to pass into the bloodstream — including raised levels of intestinal fatty acid-binding protein, lipopolysaccharide and soluble CD14.
These signs of gut inflammation can trigger wider inflammation once in circulation.
“This suggests that probably at the earliest stage of disease when patients get acute SARS-CoV-2 infection, there is a tendency that the females’ guts are more prone to viral infection,” Elahi said.
The team also observed lower red blood cell production — anaemia — in female patients, suggesting elevated inflammatory factors in women with long Covid may impair blood formation.
In addition, they reported dysregulated sex hormones in long Covid: reduced testosterone in affected women, decreased oestrogen in male patients, and lower cortisol in both.
Women with lower testosterone had higher inflammatory markers. Because testosterone can help dampen inflammation, reduced levels may leave women more vulnerable to ongoing inflammatory responses. Lower testosterone was also linked to brain fog, depression, pain and fatigue.
The findings suggest hormone imbalance plays an important role in long Covid, particularly in how it affects women, Elahi said.
These results mirror some features of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which also disproportionately affects women.
For example, chronic inflammation is common to both, although anaemia is not typically associated with chronic fatigue.
The team’s conclusions are supported by another recent international study of more than 500 patients that also identified anaemia as a major biological driver of long Covid.
Elahi plans to validate the findings by testing potential treatments in mouse models of long Covid and is seeking funding for a clinical trial.
He proposes an individualised approach guided by test results that could include anaemia treatment, anti-inflammatory medicines and, in some cases, sex hormones.
He also aims to further explore similarities between neurological symptoms of long Covid and those seen in HIV.
By WUKA sports ambassador, Hannah Miley MBE 3x Olympian & Commonwealth champion
I started swimming when I was really young, I just loved being in the water.
The pool quickly became my second home, the place where I felt most like myself. I wasn’t a natural swimmer, but I loved to work hard, and racing gave me that outlet for my competitive side.
There was something about the rhythm of the strokes, the smell of chlorine, and the quiet hum beneath the surface that made me feel free.
I got my first period around age 12, and it was daunting. My body was changing, and I didn’t know what that meant for my swimming.
Wearing a swimsuit every day made me feel exposed, and I just assumed everything I was going through (heavy bleeding that lasted up to two weeks, cramps so bad they left me doubled over) was normal.
There were moments that really knocked my confidence: not realising my tampon string was visible, or climbing out of the pool to find blood running down my leg.
At competitions, I’d sometimes sit on my towel because I’d leaked through.
The heavy bleeding left me anaemic and constantly tired, but I kept pushing through. I wanted to swim at the highest level I could even if it meant battling my body every month.
Competitions & The Pill
I’ll never forget the 2004 Commonwealth Youth Games. My period started mid-competition, and during one race, the cramps hit hard.
Swimming through that pain was frustrating, all that training felt wasted. When I saw my GP back home, I was told the best way to “fix my period problems” was to go on the pill.
Those two words, fix and problems, shaped how I thought about my body for years.
At first, the pill seemed like the perfect solution. No more painful, unpredictable periods! I ran packets back to back to skip bleeds during competitions, thinking I was being smart.
What I didn’t realise was that the seven day break wasn’t a real period at all, it was a withdrawal bleed. I thought I was in control of my cycle, but I was actually masking it.
I didn’t understand how important my hormones were for health, recovery, and performance.
On the surface, everything looked fine. Beneath that, I was struggling. Under-fuelling, getting ill before big meets, and picking up constant shoulder and knee niggles.
But I didn’t connect any of it to my hormonal health. The pill blurred the picture, and for years, I lived in fear of my period returning at the “wrong” time.
Nothing compares to the emotion you feel when you make an Olympic team.
When I realised I had qualified for my first Olympics in 2008, it was surreal the culmination of years of early mornings, long sessions, and relentless dedication.
Standing on the pool deck with “Team GB” on my kit felt like stepping into a dream that little Hannah could only have imagined.
Racing around the world, representing Scotland and Team GB, was the greatest honour of my career.
Each competition taught me more about resilience, discipline, and the incredible things the human body can do when you push it to its limits.
I went on to swim at three Olympic Games, and while each one was different, they all shaped me not just as an athlete, but as a person learning to listen to and respect her body.
It wasn’t until 2020, during lockdown, that I finally came off the pill after more than 15 years. I was speaking to Dr Georgie Bruinvels when she asked a simple but powerful question:
“When was the last time you actually had a period?”
That question stopped me in my tracks. The answer? Not since before I started the pill as a teenager, over 15 years ago.
I learned that I should have taken longer breaks to let my hormones reset after five years.
It was probably mentioned when I first started but at 15 the chances of me remembering were going to be slim. I wished someone had reminded me.
For the first time, I began tuning into my body, tracking my cycle, adjusting my nutrition, and paying attention to the signals I’d ignored for so long. The difference was incredible.
My periods now last about five days, my cramps are mild and manageable, and I finally feel in sync with my body instead of fighting against it. And no little pill to remember to take each day.
The knowledge I have now would’ve been game changing for me as a young athlete.
Finding Freedom Again — This Time, on My Period
WUKA Sports Ambassador
Becoming a WUKA Sports Brand Ambassador felt like everything coming full circle.
To work with a company whose values aligned with my mission, supporting and empowering female athletes was incredible.
As an athlete, I only ever used tampons because I thought that was my only option.
But discovering products like period underwear and period swimwear has completely changed how I feel about my body and my period.
The first time I tried WUKA period pants, I couldn’t believe how comfortable they were. No rustling, no movement, and no fear of leaks. I actually forgot I was wearing them!
And their period swimwear? Game changer. No more worrying about climbing out of the pool and noticing blood running down my leg just confidence and freedom.
I can’t help but think how different my experience as a teenager could have been if products like this had existed then.
They would’ve given me comfort, reassurance, and a sense that my period wasn’t something to hide or fear.
That’s why I’m so passionate about opening up conversations around periods in sport.
For so many young athletes, missing training isn’t an option, but competing while bleeding can be stressful and distracting.
Period-proof swimwear can take away that anxiety — letting you focus on your performance, not your period.
What I’ve Learned
My journey has taught me that periods aren’t a “problem” to be fixed, they’re a natural, powerful part of who we are.
With the right knowledge, support, and tools, we can work with our bodies, not against them.
Period proof swimwear might seem like a small thing, but for a young swimmer, it can mean the world. It can mean the difference between fear and freedom, between shame and Confidence.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
4 Comments